Developer docs
API playgroundTry for free, no card

Search company profiles

MacDougall Biomedical Communications

Full company profile

uuid000g7fm

Namestring
MacDougall Biomedical Communications
Websiteurl
macbiocom.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

MacDougall Biomedical Communications is, based on its name and the domain (macdougall.bio, redirecting to macbiocom.com), a firm operating in the biomedical communications sector — most plausibly an agency or consulting practice that provides communications, public relations, or scientific-comms services to biopharmaceutical, medical-device, and life-sciences clients. The company's exact product/service mix, client roster, and competitive positioning cannot be verified from the available source material.

No substantive information about the company's underlying technology, product portfolio, proprietary platforms, or technical architecture was captured in the input data. The company field "core_technology" is explicitly marked "Not available in source," and the proprietary-features list is empty. There is no evidence in the supplied dataset of any software product, platform, or technology stack. If the firm operates strictly as a services business, its "technology" would be its people, methodology, and client relationships rather than a deployable product.

The business model also cannot be characterized with confidence: revenue model, pricing, go-to-market motion, customer segments, and value proposition are all either empty or marked as unavailable. No revenue figure, funding history, headcount, ownership structure, founding year, operating geographies, management team, partnerships, awards, certifications, or contact details are present. The company website was inaccessible (blocked by a robot challenge/CAPTCHA page), which is the root cause of the data gap. As a result, every financial and operating claim in this description is necessarily inferred from the company name and domain only and should be treated as unverified.

Short descriptiontext

MacDougall Biomedical Communications appears, based on its name and domain (macbiocom.com), to be a biomedical communications firm providing communications services to biopharmaceutical and life-sciences clients. No products, revenue, or customer details are available in the source data.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNatick, United States
HQ citystring
Natick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biomedical communications, medical communications, scientific communications, healthcare communications, biotech communications
Industry2 codes
PRIMARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
SECONDARYHLAGALAF
Medical Affairs Scientific Communications (MSL Support/Scientific Response)
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Health Services8000
Product category
Medical Communications Services
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Based on the company name, MacDougall Biomedical Communications appears to provide biomedical/medical communications services to clients in the life sciences sector. Specific service details, scope, and deliverables cannot be confirmed because the company's website was blocked by a robot challenge screen and no substantive content was available in the source data.

Differentiator
Functional benefit
Problem solved
Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medical communications agency specializing in scientific publications and visual communications for pharmaceutical and biotech clients, directly comparable in biomedical communications offering.

TypeDirect peer
Description

Medical communications and technology-enabled scientific services provider serving pharma clients with publication planning, medical affairs, and real-world evidence communications, directly comparable offering.

TypeDirect peer
Description

Medical communications and medical affairs agency within Inizio, providing scientific content and strategic communications to pharma/biotech clients, a directly comparable peer.

TypeDirect peer
Description

Medical communications agency offering scientific content development, publications, and medical affairs services to global pharma clients, directly comparable in scope and customer base.

TypeDirect peer
Description

Global medical communications agency providing scientific publications, medical affairs, and creative services to pharma and biotech clients, directly comparable to MacDougall's biomedical communications focus.

TypeDirect peer
Description

Medical communications agency within IPG Health providing scientific content, publications, and medical affairs support to pharmaceutical clients, a directly overlapping peer in the biomedical communications space.

TypeDirect peer
Description

Independent medical communications agency specializing in scientific publications, medical affairs, and HEOR services for pharmaceutical clients, a closely analogous peer in the biomedical communications niche.

TypeBroad incumbent
Description

Broader health communications and creative agency within Inizio offering medical communications alongside advertising and patient engagement, overlapping in biomedical communications but with a wider portfolio.

9Springer Healthcare
TypeDirect peer
Description

Medical communications arm of Springer Nature providing scientific publications, medical education, and content services to pharmaceutical clients, directly comparable biomedical communications peer.

TypeDirect peer
Description

Medical communications agency within IPG Health offering medical affairs, scientific content, and publications support to pharma clients, a directly overlapping peer.

Market position
Strengths2 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key highlights2 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MacDougall Biomedical Communications

Medical Communications Servicesmacbiocom.com

MacDougall Biomedical Communications appears, based on its name and domain (macbiocom.com), to be a biomedical communications firm providing communications services to biopharmaceutical and life-sciences clients. No products, revenue, or customer details are available in the source data.

What MacDougall Biomedical Communications does

MacDougall Biomedical Communications is, based on its name and the domain (macdougall.bio, redirecting to macbiocom.com), a firm operating in the biomedical communications sector — most plausibly an agency or consulting practice that provides communications, public relations, or scientific-comms services to biopharmaceutical, medical-device, and life-sciences clients. The company's exact product/service mix, client roster, and competitive positioning cannot be verified from the available source material.

No substantive information about the company's underlying technology, product portfolio, proprietary platforms, or technical architecture was captured in the input data. The company field "core_technology" is explicitly marked "Not available in source," and the proprietary-features list is empty. There is no evidence in the supplied dataset of any software product, platform, or technology stack. If the firm operates strictly as a services business, its "technology" would be its people, methodology, and client relationships rather than a deployable product.

The business model also cannot be characterized with confidence: revenue model, pricing, go-to-market motion, customer segments, and value proposition are all either empty or marked as unavailable. No revenue figure, funding history, headcount, ownership structure, founding year, operating geographies, management team, partnerships, awards, certifications, or contact details are present. The company website was inaccessible (blocked by a robot challenge/CAPTCHA page), which is the root cause of the data gap. As a result, every financial and operating claim in this description is necessarily inferred from the company name and domain only and should be treated as unverified.

MacDougall Biomedical Communications firmographics

Firmographics
Name
MacDougall Biomedical Communications
Website
https://macbiocom.com
Company type
Private
Founded year
2002
Headcount range
11–50 employees
Short description
MacDougall Biomedical Communications appears, based on its name and domain (macbiocom.com), to be a biomedical communications firm providing communications services to biopharmaceutical and life-sciences clients. No products, revenue, or customer details are available in the source data.
Ownership category
akta.pro rank

MacDougall Biomedical Communications industry classification

Industry
Product category
Medical Communications Services
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
SECONDARYHLAGALAF
Medical Affairs Scientific Communications (MSL Support/Scientific Response)

Keywords

  • Biomedical communications
  • Medical communications
  • Scientific communications
  • Healthcare communications
  • Biotech communications

Where MacDougall Biomedical Communications is headquartered

Location

Headquarters

HQ city
Natick
HQ country
United States
HQ region
North America

Markets served

MacDougall Biomedical Communications business model

Business model
GTM type
B2B
Offering type
Services

MacDougall Biomedical Communications product offering

Product offering

Core offering

Based on the company name, MacDougall Biomedical Communications appears to provide biomedical/medical communications services to clients in the life sciences sector. Specific service details, scope, and deliverables cannot be confirmed because the company's website was blocked by a robot challenge screen and no substantive content was available in the source data.

Differentiator

Problem solved

Functional benefit

Companies that use MacDougall Biomedical Communications

Customer profile

Ideal customer profiles1 record

MacDougall Biomedical Communications technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MacDougall Biomedical Communications partnerships and signals

Strategic signal

Expansion highlights1 record

MacDougall Biomedical Communications competitors and assessment

Company assessment

Direct peers

  • Complete HealthVizion: Medical communications agency specializing in scientific publications and visual communications for pharmaceutical and biotech clients, directly comparable in biomedical communications offering.
  • Envision Pharma Group: Medical communications and technology-enabled scientific services provider serving pharma clients with publication planning, medical affairs, and real-world evidence communications, directly comparable offering.
  • ApotheCom (Inizio): Medical communications and medical affairs agency within Inizio, providing scientific content and strategic communications to pharma/biotech clients, a directly comparable peer.
  • Nucleus Global: Medical communications agency offering scientific content development, publications, and medical affairs services to global pharma clients, directly comparable in scope and customer base.
  • Fishawack Health (Avalere Health): Global medical communications agency providing scientific publications, medical affairs, and creative services to pharma and biotech clients, directly comparable to MacDougall's biomedical communications focus.
  • Caudex (IPG Health): Medical communications agency within IPG Health providing scientific content, publications, and medical affairs support to pharmaceutical clients, a directly overlapping peer in the biomedical communications space.
  • Oxford PharmaGenesis: Independent medical communications agency specializing in scientific publications, medical affairs, and HEOR services for pharmaceutical clients, a closely analogous peer in the biomedical communications niche.
  • Springer Healthcare: Medical communications arm of Springer Nature providing scientific publications, medical education, and content services to pharmaceutical clients, directly comparable biomedical communications peer.
  • CMC Connect (IPG Health): Medical communications agency within IPG Health offering medical affairs, scientific content, and publications support to pharma clients, a directly overlapping peer.

Broad incumbents

  • Ashfield Health (Inizio): Broader health communications and creative agency within Inizio offering medical communications alongside advertising and patient engagement, overlapping in biomedical communications but with a wider portfolio.

Market position

Strengths2 records

Competitive moat1 record

Key highlights2 records

Customer concentration

MacDougall Biomedical Communications social profiles

Digital presence

MacDougall Biomedical Communications financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MacDougall Biomedical Communications leadership team

Management profile

Number of profiles

MacDougall Biomedical Communications funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MacDougall Biomedical Communications M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MacDougall Biomedical Communications

What does MacDougall Biomedical Communications do?

Based on the company name, MacDougall Biomedical Communications appears to provide biomedical/medical communications services to clients in the life sciences sector. Specific service details, scope, and deliverables cannot be confirmed because the company's website was blocked by a robot challenge screen and no substantive content was available in the source data.

When was MacDougall Biomedical Communications founded?

MacDougall Biomedical Communications was founded in 2002. It employs 11 to 50 people.

Where is MacDougall Biomedical Communications based?

MacDougall Biomedical Communications is headquartered in Natick, United States, in the North America region.

Who are MacDougall Biomedical Communications's main competitors?

Direct peers on record are Complete HealthVizion, Envision Pharma Group, ApotheCom (Inizio), Nucleus Global, Fishawack Health (Avalere Health), Caudex (IPG Health), Oxford PharmaGenesis, Springer Healthcare and CMC Connect (IPG Health). Ashfield Health (Inizio) is listed as a broad incumbent.

Does MacDougall Biomedical Communications have an API?

No public API is recorded for MacDougall Biomedical Communications.

What industry is MacDougall Biomedical Communications in?

MacDougall Biomedical Communications's product category is Medical Communications Services. Its primary akta.pro industry code is MPAAADAD, Healthcare & Life Sciences PR, with a secondary code of HLAGALAF, Medical Affairs Scientific Communications (MSL Support/Scientific Response). Its NAICS code is 54169 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals